Key facts
- This page summarizes Elaine J. Heron's Form 4 filing for BIOMARIN PHARMACEUTICAL INC (BMRN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jun 2024, 19:29.
Elaine J. Heron - 03 Jun 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)
- Reporting relationship
- Director
- Issuer ticker
- BMRN
- Reported as of
- 03 Jun 2024
- Net transaction value
- -$11.18
- SEC form
- 4
- Accepted by SEC
- 04 Jun 2024, 19:29:46 UTC
- Prior SEC filing
- 23 May 2024
- Next SEC filing
- 12 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tae Sang Yoo, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Elaine J. Heron filed Form 4 for BIOMARIN PHARMACEUTICAL INC (BMRN) on 04 Jun 2024.
Change
- Previous filing in this sequence was filed on 23 May 2024.
- Current net transaction value: -$11.18.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BMRN
transaction
Common Stock
Options Exercise
- Transaction value
- $318,466
- Shares
- +5,047
- Change %
- +5.2%
- Price
- $63.10
- Shares after
- 101,888
- Date
- 03 Jun 2024
- Ownership
- Direct
BMRN
transaction
Common Stock
Tax liability
- Transaction value
- $318,477
- Shares
- -4,168
- Change %
- -4.1%
- Price
- $76.41
- Shares after
- 97,720
- Date
- 03 Jun 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BMRN
transaction
Derivative
Stock Option (Right to Buy Common Stock)
Options Exercise
- Transaction value
- $0
- Shares
- -5,047
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 03 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,047
- Exercise price
- $63.10
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Reflects the number of options outstanding after the transactions from this specific stock option grant.